ArticleRenal failure2026
Lower eGFR is independently associated with embolization‑requiring severe bleeding after percutaneous renal biopsy: a matched case-control study with dose-respons e analysis.
Article in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundReduced estimated glomerular filtration rate (eGFR) is a suspected risk factor for bleeding after percutaneous renal biopsy, but its association with hemorrhage requiring embolization is unclear. We evaluated this association using a matched case‑control study.
methodsThis single‑center, retrospective, matched case‑control study included patients who underwent ultrasound‑guided native renal biopsy between 2012 and 2025 at a Chinese tertiary hospital. Cases (
resultsIn fully adjusted models, each 1 mL/min/1.73m
conclusionsLower eGFR may be independently associated with increased risk of embolization-requiring bleeding after renal biopsy in a linear dose-response manner. Given the limited sample size, these exploratory findings require validation in larger, prospective cohorts. eGFR may aid in preoperative risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.